Gilead in pact for anti-inflammatory drugs in a deal worth up to $1.7B
Gilead Sciences (NASDAQ:GILD) and Danish pharmaceutical company LEO Pharma on Saturday announced an agreement worth up to ...
Gilead, LEO Pharma partner to develop programs for inflammatory diseases
The Danish company will be eligible to receive up to $1.7 billion in payments which include an upfront payment of $250 ...